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Abstract
Cognitive decline is a significant complication that affects most stroke survivors. Early detection of cognitive decline in ischemic stroke patients and identification
of risk factors improves their clinical outcomes. This study aimed to determine the characteristics of cognitive status in the sub-acute phase of ischemic stroke.
A cross-sectional study was conducted on 89 sub-acute ischemic stroke patients in three hospitals in West Nusa Tenggara recruited consecutively from
August 2019 to April 2020. The data collected were demographic and clinical characteristics, cognitive status, and functional outcome. The association
between clinical and demographic characteristics and cognitive decline was analyzed using logistic regression. In addition, the relationship between cognitive
status and functional outcomes of these patients was examined using the chi-square test. This study revealed that the prevalence of cognitive decline in these
subjects was 71.9%. Multiple logistic regression showed that age was the only characteristic associated with cognitive decline in the subjects (OR = 5.12,
95% CI = 1.08-24.28). Furthermore, the frequency of cognitive decline in these subjects was significantly associated with functional outcomes (p-value =
0.014). Thus, there was a high prevalence of cognitive decline in sub-acute ischemic stroke patients associated with increasing age and poor functional out-
comes.
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Introduction
Cognitive decline is considered an essential complica-
tion of ischemic stroke, increasing to 80% in a few weeks
post-stroke.1 It may involve one or more cognitive do-
mains ranging from mild to that which interferes with
functional capacities, regardless of their neurological
deficits.2 Approximately 59% of mild ischemic stroke
patients of productive age and higher education level re-
main unable to return to work after six months of follow-
up due to stroke-related cognitive decline.3 On long-term
evaluation, about 30% of ischemic stroke patients with
cognitive decline tend to be stable in the first four years
or even progress to dementia if not appropriately treat-
ed.4 These patients will eventually increase the health,
social, and economic burden on their careers, families,
and the healthcare system.5 Meanwhile, early interven-
tion of cognitive decline after ischemic stroke may delay
its progression to dementia and provide better clinical
outcomes.6 Therefore, early evaluation of cognitive func-
tion in ischemic stroke patients, especially in the sub-
acute phase, is important.
Typically, older age, lower educational level, hyper-
tension, diabetes mellitus, atrial fibrillation, brain region
affected, and size and location of infarction are the clin-
ical and demographic characteristics known as risk fac-
tors for cognitive decline after ischemic stroke.7 Older
age is the most important independent risk factor for the
cognitive decline from all causes, including stroke.6
Among the well-identified vascular risk factors, hyper-
tension and diabetes mellitus are the most critical risk
factors for cognitive decline in the general population.8
Therefore, in most cases, it is difficult to ascertain
whether the cognitive decline observed in patients after
ischemic stroke is solely due to an ischemic stroke event.
However, cognitive decline after ischemic stroke is pre-
dominantly due to interactions between the ischemic
stroke event and risk factors for cognitive decline after
ischemic stroke.1 Therefore, the intervention of the risk
factors for ischemic stroke must also be considered to
manage cognitive decline after ischemic stroke.
Regarding the evaluation of cognitive function among
ischemic stroke patients, previous studies had employed
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diverse research methods, determining the appropriate
time frame and selection of instruments for the assess-
ment of cognitive function.2 Previous studies also showed
diversity in the ethnicity of the subjects, which could in-
crease the variability of the demographic characteristics
of the patients and modified their susceptibility to cogni-
tive decline after ischemic stroke.9 However, similar
studies that have evaluated the cognitive functions among
these patients remained scarce, including those in
Indonesia.
Determining the appropriate time for evaluating cog-
nitive function among ischemic stroke patients to provide
relevant results to be used as a basis for early intervention
in cognitive decline in these subjects is also important.
Several studies have evaluated the acute and sub-acute
outcomes beyond three months after the onset of is-
chemic stroke, with or without the follow-up of the pro-
gression of cognitive decline.10,11 The primary data col-
lection on cognitive status and cognitive decline early de-
tection in post-ischemic stroke patients is mandatory. It
is based on cognitive decline after the ischemic stroke
that can improve due to activities of neural plasticity in
the brain that generally occur optimally in the first three
months.12 In the acute stage of ischemic stroke, patients
can experience delirium due to ischemic stroke-associat-
ed cerebral edema and the involvement of the right hemi-
sphere, affecting patients’ performance in the evaluation
of cognitive function.13,14 Since cerebral edema generally
undergoes resolution within the first weeks, the assess-
ment of cognitive disorders should be performed in the
sub-acute stage.15
This study aimed to investigate the cognitive status of
the sub-acute stage in patients with ischemic stroke. This
is the first study conducted in a sub-population of is-
chemic stroke patients in the sub-acute stage of rural a -
reas in West Nusa Tenggara to represent the rural regions
in Indonesia. The results of this study are essential for lo-
cal health authorities to assess the importance of early
detection and management of cognitive decline in the
sub-acute stage of ischemic stroke.
Method
This study employed a cross-sectional design that in-
volved ischemic stroke patients in the sub-acute stage
consecutively recruited in Nusa Tenggara Barat General
Hospital, Mataram General Hospital, and Siti Hajar
Hospital. This study was conducted between August
2019 and April 2020. The sample size was calculated us-
ing the sample calculation formula (Zα2PQ)/d2. Since α
= 0.05, Zα = 1.96, P (prevalence) = 70%, Q = 1-P, and
d (margin of error) = 10%, the sample size was 81. Eight
samples (10% of the calculated sample size) were added;
thus, the final sample size of the study was 89.
The inclusion criteria for the subjects were ischemic
stroke confirmed by head computed tomography (CT) in
the sub-acute stage (2–12 weeks after stroke onset). The
subjects were fully conscious, aged 40-70 years, with at
least a primary school graduation (6-year-education). The
age of the subjects was determined to be between 40-70
years to minimize the confounding effect of the possibility
of cognitive decline related to neurodegenerative process-
es in patients above 70 years of age.16 This study em-
ployed a cognitive evaluation instrument that required
patient awareness of the concept of time and aspects of
knowledge. This concept was only obtained when the pa-
tient reached the fourth grade and was established at the
sixth grade of elementary school education level. For this
reason, the subjects were selected to have a minimum
edu cation level of primary school graduates. 
Meanwhile, the exclusion criteria for the subjects
were patients with significant vision and hearing disor-
ders that could not be corrected, prior history of demen-
tia, psychiatric disorders, benzodiazepines, antipsy-
chotics, and antidepressant medication at the time of cog-
nitive evaluation. This study was approved by the Health
Research Ethics Commission of Universitas Mataram
(Register number: 214/UN18.F7/ETIK/2019). All sub-
jects provided written informed consent before partici-
pation.
Demographic and clinical variables collected in this
study were age, gender, level of education, side of the le-
sion in the brain based on head CT scan, infarction size,
hypertension, diabetes mellitus, cigarette smoking, atrial
fibrillation, cognitive status, and functional outcomes.
Before data analysis, categorization of both demographic
and clinical characteristics was performed. In terms of
the demographic characteristics of the subjects, age was
categorized as young adults (40–59 years) and older (60–
70 years); gender was categorized as male or female, and
level of education was categorized as elementary school,
high school, and college.
Based on the head CT scan examination results, the
side of the lesion in the brain was classified as the right
hemisphere, left hemisphere, and bilateral. In contrast,
infarction size was categorized into small (≤5 mm in di-
ameter), medium (6-14 mm in diameter), and large (≥15
mm in diameter), which was a modification of the cate-
gories used in previous studies.17,18 Subjects were cate-
gorized as having hypertension if they had a systolic
blood pressure of ≥140 mmHg, and/or diastolic blood
pressure ≥90 mmHg, and/or any use of antihypertensive
medication, and/or self-reported history of hypertension.
They were categorized as having diabetes mellitus if they
had fasting blood glucose levels of ≥126 mg/dL (7.0
mmol/L), and/or any use of anti-diabetic medication,
and/or self-reported history of diabetes mellitus as de-
scribed in previous studies.19,20 In terms of ci garette
smoking, subjects were categorized as smokers and non-
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smokers. Twelve-lead electrocardiogram (ECG) exami-
nations were performed on all subjects, and an indepen -
dent cardiologist reviewed the results to identify the pre -
sence of atrial fibrillation.
Cognitive status was determined based on the grade
of the Montreal Cognitive Assessment in the Indonesian
version (MoCA-Ina) score. The MoCA-Ina is an instru-
ment for evaluating global cognitive functions that have
been validated for Indonesian populations.21 Its total
score ranges from 0–30. Subjects with a score of 26–30
were categorized as normal, while those with 0–25 were
indicated to have a cognitive decline. Subjects with an
education time of <12 years were given an additional
score of 1 as a correction factor for the effects of educa-
tion. 
The functional outcome of patients was established
based on the Barthel index (BI) score. The Barthel index
is a valuable instrument for assessing the functional out-
come of subjects with ischemic stroke regarding their in-
dependence in carrying out basic daily activities.22 This
instrument has a score in the range of 0–100. Subjects
with a score of 80–100 were categorized as functionally
independent, while those with 0–79 were classified as
functionally dependent as described in the previous
study.23
The first analysis was carried out to verify the associ-
ation between demographic and clinical variables and
cognitive status in the sub-acute stage of ischemic stroke.
In this step, the association between categorical inde-
pendent variables, including age, gender, level of educa-
tion, side of the lesion in the brain, infarction size, hyper-
tension, diabetes mellitus, cigarette smoking, atrial fib-
rillation, and cognitive status of the subjects were initially
analyzed using simple binary logistic regression and
crude odds ratio (OR) with 95% confidence interval
(CI). In the second analysis, the independent variables
(p-value <0.25 in simple binary logistic regression analy-
sis) were then grouped into multiple logistic regression
models and had the OR adjusted with 95% CI. The third
analysis was administered using the chi-square test to as-
certain the relationship between these subjects’ cognitive
status and functional outcomes. Statistical significance
was set at p-value <0.05. 
Results
Table 1 shows the results of simple binary logistic re-
gression analysis examining the association between de-
mographic and clinical variables and cognitive decline
among subjects with ischemic stroke in the sub-acute
stage (n = 89). This analysis revealed that age group and
infarction size were the eligible variables for the final
model of multiple logistic regression (p-value <0.25).
Although only age had a significant association (OR =
4.86, 95%CI = 1.04–22.68), medium (OR = 3.17, 95%
CI = 0.69–14.46) and large infarct size (OR = 3.06, 95%
CI = 0.78–11.10) also appeared to modulate an increased
Table 1. Simple Binary Logistic Regression Analysis Showing Variables Associated with Cognitive Decline in the Sub-Acute Stage of Ischemic Stroke
                                                                                                                  Cognitive Status
Variable                       Category                                        Normal (n = 25)                  Decline (n = 64)                 Crude OR (95% CI)                 p-value
                                                                                           n                  %                      n               %
Age group                    Older                                               2                 9.5                    19             90.5                       4.86 (1.0–22.68)                  0.040*
                                    Young adult                                   23               33.8                    45             66.2                                   Reference                             
Gender                         Male                                               20               31.2                    44             68.8                       1.82 (0.60–5.54)                    0.293
                                    Female                                             5               20.0                    20             80.0                                   Reference                             
Level of education       College                                            8               27.6                    21             72.4                         1.31 (0.4–3.76)                    0.612
                                    High school                                    13               33.3                    26             66.7                         0.62 (0.1–2.41)                    0.487
                                    Elementary school                            4               19.0                    17             81.0                                   Reference                             
Side of the lesion         Right hemisphere                           10               27.8                    26             72.2                       1.04 (0.29–3.69)                    0.952
                                    Left hemisphere                             10               28.6                    25             71.4                       1.00 (0.28–3.54)                    1.000
                                    Bilateral                                           5               27.8                    13             72.2                                   Reference                             
Infarction size              Large (>15 mm)                              3               13.6                    19             86.4                     3.17 (0.69–14.46)                  0.137*
                                    Medium (6-14 mm)                         7               33.3                    14             66.7                     3.06 (0.78–11.10)                  0.108*
                                    Small (<5 mm)                              15               32.6                    31             67.4                                   Reference                             
Hypertension               Yes                                                 21               26.2                    59             73.8                       0.44 (0.11–1.82)                    0.259
                                    No                                                    4               44.4                      5             55.6                                   Reference                             
Diabetes mellitus         Yes                                                   9               26.5                    25             73.6                       0.88 (0.34–2.29)                    0.789
                                    No                                                  16               29.1                    39             70.9                                   Reference                             
Cigarette smoking        Smokers                                         12               34.3                    23             65.7                       1.64 (0.64–4.20)                    0.297
                                    Non-smokers                                  13               24.1                    41             75.9                                   Reference                             
Atrial fibrillation          Yes                                                   0                 0.0                      7           100.0                       0.00 (0.00–0.00)                    0.999
                                    No                                                  25               30.5                    57             69.5                                   Reference                             
Notes: *eligible for multiple logistic regression analysis, OR: Odds Ratio, CI: Confidence Interval
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risk of ischemic stroke-associated cognitive decline.
Table 2 shows the results of the final model of multi-
ple logistic regression analysis in examining the associa-
tion between eligible variables and cognitive decline
among subjects with ischemic stroke in the sub-acute
stage (n = 89). This final model of multiple logistic re-
gression revealed that age was the only variable associat-
ed with cognitive decline in the subjects (OR = 5.12,
95% CI = 1.08-24.28). Consistent with the simple logis-
tic regression analysis results presented previously, older
subjects had a greater risk of ischemic stroke-associated
cognitive decline. 
Table 3 shows the chi-square test results in investi-
gating the association between cognitive status and func-
tional outcomes of ischemic stroke patients in the sub-
acute stage. The chi-square test revealed that cognitive
status was associated with the clinical outcomes of the
subjects (p-value = 0.014). Subjects with ischemic
stroke-associated cognitive decline had higher functional
dependence than those with normal cognitive status.
Discussion
This initial study aimed to investigate the characteris-
tics of cognitive status in the sub-acute stage of ischemic
stroke in West Nusa Tenggara, representing rural areas
in Indonesia. This study showed a high prevalence of cog-
nitive decline in the sub-acute stage of ischemic stroke,
amounting to 71.9%. This result was in line with the
findings of previous studies.24,25 Therefore, this result
added to previous data on the prevalence of ischemic
stroke-associated cognitive impairment. Since the major-
ity of ischemic stroke continues to increase with higher
survival rates in its patients, including in Indonesia, the
results of this study suggested that ischemic stroke-asso-
ciated cognitive decline has the potential to become a sig-
nificant health problem in the future. The relatively con-
sistent data on the prevalence of ischemic stroke-associat -
ed cognitive decline between this study and previous
studies also suggested that ischemic stroke-associated
cognitive decline will also become a global health pro -
blem, both in urban and rural areas. Suppose an adequate
management strategy is not developed earlier. In that
case, this health problem has the potential to cause a de-
crease in their productivity and an increase in the eco-
nomic burden of their families and the existing healthcare
system. 
This study also showed that increasing age was the
only variable significantly associated with cognitive de-
cline in the sub-acute stage of ischemic stroke in West
Nusa Tenggara. The results of this study were in accor-
dance with previous studies, which showed that increas-
ing age was the most substantial risk factor for post-
stroke cognitive decline, including in ischemic stroke.6,26
Since patients over 70 years old were excluded from this
study, the role of neurodegenerative processes predomi-
nantly involving brain amyloid-beta (Aβ) deposition in
Table 2. The Final Model of Multiple Logistic Regression Showing Eligible Variables Associated with Cognitive Decline in the Sub-Acute Stage of 
              Ischemic Stroke
                                                                                                                  Cognitive Status
Variable                       Category                                        Normal (n = 25)                  Decline (n = 64)                 Crude OR (95% CI)                 p-value
                                                                                           n                  %                      n               %
Age group                    Older                                               2                 9.5                    19             90.5                     5.12 (1.08–24.28)                  0.040*
                                    Young adult                                   23               33.8                    45             66.2                                   Reference                             
Infarction size              Large (>15 mm)                              3               13.6                    19             86.4                     3.38 (0.72–15.95)                    0.124
                                    Medium (6-14 mm)                         7               33.3                    14             66.7                     3.27 (0.81–13.12)                    0.095
                                    Small (<5 mm)                              15               32.6                    31             67.4                                   Reference                             
Notes: *significant association, OR: Odds Ratio, CI: Confidence Interval
Table 3. The Association between Cognitive Status and Functional Outcomes of the Subjects with
              Sub-Acute Stage of Ischemic Stroke
                                                                                     Cognitive Status
Functional Outcome                           Normal (n = 25)                 Decline (n = 64)                  p-value
                                                              n             %                       n              %
Functionally independent                      25           32.5                    52            67.5                      0.014*
Functionally dependent                           0             0.0                    12          100.0                                  
                                                                 
Notes: *significant difference (p-value <0.05), chi-squared test
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the presence of a cognitive decline in patients with sub-
acute ischemic stroke is unlikely. The negative impact of
increasing age on cognitive flexibility needs to be consid-
ered to play an important role in the pathophysiology of
cognitive decline after stroke. Povroznik, et al.,27 showed
that increasing age exacerbates stroke-related cognitive
flexibility deficits, leading to cognitive decline in stroke
patients. Since the success of cognitive impairment inter-
ventions is primarily determined by the patients’ ability
to understand the instructions given during the interven-
tion program, the management of ischemic stroke-asso-
ciated cognitive decline associated with ischemic stroke
in elderly patients will be a challenge for existing health-
care providers in the province of West Nusa Tenggara.
Therefore, these results can be considered as a basis for
the development of intervention strategies for ischemic
stroke-associated cognitive decline by health authorities
in this province.
However, other variables, including gender, level of
education, lesion side in the brain, infarction size, hyper-
tension, diabetes mellitus, cigarette smoking, and atrial
fibrillation, were not related to cognitive decline in the
patients. In general, the level of education of the popula-
tion living in rural areas is lower than that of those living
in urban areas, which will cause a higher prevalence of
cognitive decline after ischemic stroke in rural areas com-
pared to those in urban areas.10 Nonetheless, previous
studies investigating the risk factors for cognitive decline
in ischemic stroke, including increasing age, level of ed-
ucation, ethnicity, geography, hypertension, diabetes mel-
litus, brain region affected, cardioembolic type of is-
chemic stroke, and the size and location of infarction had
shown varied results. Zulkifly, et al.,7 showed that the
level of education, hypertension, diabetes mellitus, brain
region affected, and the size and location of infarction
were variables related to cognitive decline after stroke.
In contrast, Levine, et al.,28 showed that age and car-
dioembolic stroke were the main risk factors for cognitive
decline. These varying results were determined primarily
by the study population, methods, and cognitive evalua-
tion tools used. Nevertheless, intervention on modifiable
vascular risk factors remains an essential part of the man-
agement strategy for cognitive decline after ischemic
stroke.
This study also indicated that the cognitive status of
the sub-acute stage of ischemic stroke was associated
with their functional outcome measured using the Barthel
Index (BI) score. The frequency of the sub-acute stage of
ischemic stroke patients who were functionally depend-
ent in performing basic activities of daily living was high-
er than in those with normal cognitive function. This re-
sult was also in accordance with previous studies con-
ducted by Abzhandadze, et al.,29 and Li, et al.22 Early re-
habilitation therapy is the most important factor that de-
termines the significance of cognitive status and func-
tional outcomes in ischemic stroke patients. Since brain
plasticity is optimally improved within the first three
months, early rehabilitation therapy should be initiated
during this period. Therefore, this result can also be used
to develop rehabilitation strategies for stroke-related cog-
nitive decline by local health authorities. 
This study had some limitations. The first was dealing
with the lack of facilities used to establish a diagnosis of
cognitive decline in the sub-acute stage of ischemic
stroke. Since the CT scan was the only diagnostic facility
available in this study, the clinical characterization of is-
chemic stroke was difficult to achieve. This hinders the
presentation of data on the analysis of the relationship
between clinical characteristics and cognitive decline in
ischemic stroke patients in more detail. The second was
the absence of baseline data on cognitive status prior to
stroke events from the subjects in this study. It was diffi-
cult to determine whether this cognitive decline was from
a pre-existing condition or as a result of an ischemic
stroke event.
Nevertheless, the results of this study can be used as
a basis for developing detection and intervention strate-
gies by local health authorities in West Nusa Tenggara
and other parts of Indonesia having similar characteris-
tics. It was based on data for the prevalence of cognitive
decline associated with sub-acute ischemic stroke, and
its risk factors were still very limited, especially among
Indonesian populations living in rural regions. A longitu-
dinal study aimed at investigating the benefits of early in-
tervention in the sub-acute stage of ischemic stroke pa-
tients on cognitive improvement and functional out-
comes is needed.  
Conclusion
The present study revealed a high prevalence of cog-
nitive decline in the sub-acute stage of ischemic stroke.
Age was the only variable significantly associated with
cognitive decline. The sub-acute stage of ischemic stroke
in patients with increasing age has a higher risk of cogni-
tive decline. The high prevalence of cognitive decline in
these subjects was associated with poor functional out-
comes. These results add to previous data regarding the
characteristics of stroke-associated cognitive decline in
Indonesia and other developing countries. More impor-
tantly, these results can be used as a basis for developing
strategies for early detection, intervention, and rehabili-
tation of stroke-related cognitive decline in West Nusa
Tenggara and other regions in Indonesia with similar
characteristics. 
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